Detalles de la búsqueda
1.
Cluster Headache Genomewide Association Study and Meta-Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor.
Ann Neurol
; 94(4): 713-726, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37486023
2.
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world.
J Neurol Neurosurg Psychiatry
; 2024 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38777579
3.
Improvement of migraine depressive symptoms is not related to headache frequency: exploring the impact of anti-CGRP therapies.
Cephalalgia
; 44(2): 3331024231222923, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38307497
4.
Quantifying sensory thresholds along the migraine cycle: An exploratory longitudinal study.
Cephalalgia
; 44(2): 3331024241230279, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38416486
5.
Dynamic fluctuations of salivary CGRP levels during migraine attacks: association with clinical variables and phenotypic characterization.
J Headache Pain
; 25(1): 58, 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38637736
6.
Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age population.
J Headache Pain
; 25(1): 21, 2024 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38347485
7.
Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in Migraine.
Ann Neurol
; 92(5): 846-859, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36054144
8.
The impact of epigenetic mechanisms in migraine: Current knowledge and future directions.
Cephalalgia
; 43(2): 3331024221145916, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36759209
9.
Patterns of response to anti-calcitonin gene-related peptide monoclonal antibodies during first 6 months of treatment in resistant migraine patients: Impact on outcome.
Eur J Neurol
; 30(7): 1937-1944, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37038303
10.
Migraine worsening after COVID-19 and COVID-19 vaccination: Are we facing a nocebo effect?
Eur J Neurol
; 30(12): 3877-3885, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37791410
11.
The Role of Glial Cells in Different Phases of Migraine: Lessons from Preclinical Studies.
Int J Mol Sci
; 24(16)2023 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37628733
12.
Exploring sensory sensitivity, cortical excitability, and habituation in episodic migraine, as a function of age and disease severity, using the pattern-reversal task.
J Headache Pain
; 24(1): 104, 2023 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37545005
13.
Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks.
Cephalalgia
; 42(3): 186-196, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34601944
14.
Avoidance behaviour modulates but does not condition phonophobia in migraine.
Cephalalgia
; 42(13): 1305-1316, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35815637
15.
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients.
Cephalalgia
; 42(8): 804-809, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35166156
16.
The relationship of headache as a symptom to COVID-19 survival: A systematic review and meta-analysis of survival of 43,169 inpatients with COVID-19.
Headache
; 62(8): 1019-1028, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36053077
17.
Neurophysiological correlates of abnormal auditory processing in episodic migraine during the interictal period.
Cephalalgia
; 41(1): 45-57, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32838536
18.
Partial and nonresponders to onabotulinumtoxinA can benefit from anti-CGRP monoclonal antibodies preventive treatment: A real-world evidence study.
Eur J Neurol
; 28(7): 2378-2382, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33730441
19.
The impact of a digital platform on migraine patient-centered outcome research. Evaluation of midolordecabeza.org, a headache website in Spanish.
Headache
; 61(9): 1403-1410, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34601726
20.
Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months.
J Headache Pain
; 22(1): 120, 2021 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34620085